News | April 26, 2024
Merck 1Q 2024 sales up 9% to US$ 15.8 billion
Sales reflect continued strong growth in oncology and vaccines
Sales reflect continued strong growth in oncology and vaccines
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
The ANDA was filed as 'First to File' submission on NCE-1 date.
Phase 2 study evaluating an investigational weekly oral combination treatment regimen of islatravir and Gilead Sciences’ lenacapavir to resume with lower dose of islatravir
Company creates Younger T Cells for fighting cancer using its NR2F6 technology
She joins Enveda from Gilead Sciences
Subscribe To Our Newsletter & Stay Updated
